Role of Beta HCG and AFP in Prediction of Hypertensive Disorder in Pregnancy in Second Trimester- A Hospital Based Prospective Study
DOI:
https://doi.org/10.21276/0vvsrh97Keywords:
Pre-eclampsia, Hypertension, β-HCG, AFPAbstract
Background: Pre-eclampsia is an important cause of maternal and neonatal complication and death. If hypertension in pregnancy is diagnosed at an early age, we can provide an efficient care to mother for good outcome of pregnancy. The aim of this study to evaluated the role of B-HCG and AFP as predictors of HDP.
Methods: This prospective Investigation study was conducted on 100 pregnant women attending the antenatal clinic in Department of Obstetrics and Gynaecology, Jaipur. Estimation of serum β-HCG and AFP was done by ELISA technique. Then there finding were correlated with the value of serum β-HCG and AFP in second trimester to see whether there is any relation between levels of serum β- HCG and AFP in second trimester and development of HDP.
Results: ‘Out of 100 women, 5 i.e. 5% were <20 years of age, maximum i.e. 62 (62%) were in 21-25 years of age group, 25 (25%) were in 26-30 years of age group and 8 (8%) were in 31-35 years age of group. Significantly higher mean S. β-HCG (mIU/ml) was observed in HDP group i.e. 13450.5±3420.8 as compared to 7732±2024 in normotensive group and a test of full model was statistically significant indicating that the predictors reliably distinguish between HDP group and normotensive group (Chi square 55.328, df 4, p<.001).
Conclusion: We conclude from this study the measurement of serum β-HCG and AFP should be routinely done in second trimester of pregnancy, to predict the occurrence of HDP for better fetomaternal outcome.
Downloads
References
James PR, Nelson-Piercy. Management of Hypertension before, during, and after pregnancy. Heart. 2004;90:1499-1504.
Khan KS, Wojdyla D, Say L et al. WHO analysis of causes of maternal death: a systematic review. Lancet.2006;367:1066-74.
Baschat AA, Madger LS, Doyle LE, et al. Prediction of preeclampsia utilizing the first trimester screening examination. Am J Obstet Gynecol 2014; 211: 524.e1-524.e7.
Sibai B, Dekker G, Kupferminc M: Preeclampsia. Lancet. 2005;365: 785- 99.
Conde-Agudelo A, Romero R, Roberts JM: Tests to predict preeclampsia. In Taylor RN, Roberts JM, Cunningham FG(eds): Chesley’s Hypertensive Disorders in Pregnancy, 4th ed. Amsterdam, Academic Press,2014.
Revankar VM, Narmada L. Assessment of serum β-hCG and lipid profile in early second trimester as predictors of hypertensive disorders of pregnancy. Int J Gynaecol Obstet. 2017 Sep;138(3):331-334.
Munirah Md Mansor. Early Second Trimester hCG of Maternal Serum as Predictor Marker for Pregnancy Induced Hypertension. - Medicine & Health, June 2018: DOI: 10.17576/MH.2018.1301.14.
Stamilio DM, Sehdev HM, Morgan MA, Propert K, Macones GA. Can antenatal clinical and biochemical markers predict the development of severe preeclampsia? Am J Obstet Gynecol 2000;182(3):589-94.
Räty R, Koskinen P, Alanen A, Irjala K, Matinlauri I, Ekblad U. Prediction of pre-eclampsia with maternal mid-trimester total renin, inhibin A, AFP and free betahCG levels. Prenat Diagn 1999;19(2):122-7.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 International Archives of BioMedical and Clinical Research
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors are required to sign and submit the completed “Copyright transfer Form” upon acceptance of publication of the paper. This is determined by a publishing agreement between the author and International Archives of Biomedical and Clinical Research. These rights might include the right to publish, communicate and distribute online. Author(s) retain the copyright of their work. International Archives of Biomedical and Clinical Research supports the need for authors to share, disseminate and maximize the impact of their research.
